SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001753926-24-000441
Filing Date
2024-03-01
Accepted
2024-03-01 17:07:11
Documents
1
Group Members
3I MANAGEMENT LLCMAIER JOSHUA TARLOW

Document Format Files

Seq Description Document Type Size
1 SC 13G g084088_13g.htm SC 13G 75375
  Complete submission text file 0001753926-24-000441.txt   76997
Mailing Address 140 BROADWAY 38TH FLOOR NEW YORK NY 10005
Business Address 874 WALKER ROAD SUITE C DOVER DE 19904 (646) 845-0040
3i, LP (Filed by) CIK: 0001841619 (see all company filings)

IRS No.: 843800874 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Subject) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94460 | Film No.: 24711413
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)